Vincent Auffret
Overview
Explore the profile of Vincent Auffret including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
1229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leurent G, LOfficial G, Anselmi A, Donal E, Auffret V
EuroIntervention
. 2025 Mar;
21(5):e285-e286.
PMID: 40028732
No abstract available.
2.
Nolf M, Boulmier D, Leurent G, Tomasi J, Le Bars F, Bakhti A, et al.
Arch Cardiovasc Dis
. 2025 Feb;
PMID: 39924380
Background: Transcatheter aortic valve implantation may be associated with significant haemorrhagic complications. Aims: To evaluate the timing, incidence, predictors and clinical impact of bleeding events after transcatheter aortic valve implantation,...
3.
Gonzalvez-Garcia A, Cepas-Guillen P, Ternacle J, Urena M, Alperi A, Cheema A, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Dec;
PMID: 39722415
Introduction And Objectives: The Valve Academic Research Consortium (VARC)-3 definition of the early safety (ES) composite endpoint after transcatheter aortic valve replacement (TAVR) lacks clinical validation. The aim of this...
4.
Mengi S, Cepas-Guillen P, Cepas-Guillen P, Ternacle J, Urena M, Alperi A, et al.
Can J Cardiol
. 2024 Dec;
PMID: 39667494
Background: Atrial fibrillation (AF) has been identified as a marker of advanced cardiac damage in patients with aortic stenosis. However, the factors associated with poorer outcomes among AF patients in...
5.
Donal E, Dreyfus J, Leurent G, Coisne A, Leroux P, Ganivet A, et al.
JAMA
. 2024 Nov;
333(2):124-132.
PMID: 39602173
Importance: Correction of tricuspid regurgitation using tricuspid transcatheter edge-to-edge repair (T-TEER) in addition to guideline-directed optimized medical therapy (OMT) may improve clinical outcomes. Objective: To evaluate the efficacy of T-TEER ...
6.
Avvedimento M, Cepas-Guillen P, Ternacle J, Urena M, Alperi A, Cheema A, et al.
Circ Cardiovasc Interv
. 2024 Oct;
18(1):e014800.
PMID: 39475194
Background: The Valve Academic Research Consortium for High Bleeding Risk (VARC-HBR) has recently introduced a consensus document that outlines risk factors to identify high bleeding risk in patients undergoing transcatheter...
7.
Peschanski N, Zores F, Boddaert J, Douay B, Delmas C, Broussier A, et al.
Arch Cardiovasc Dis
. 2024 Oct;
118(1):6-16.
PMID: 39455316
No abstract available.
8.
Peschanski N, Zores F, Boddaert J, Douay B, Delmas C, Broussier A, et al.
Arch Cardiovasc Dis
. 2024 Sep;
117(11):639-646.
PMID: 39261191
No abstract available.
9.
Hauguel-Moreau M, Guedeney P, Dauphin C, Auffret V, Clerc J, Marijon E, et al.
Circulation
. 2024 Sep;
150(21):1659-1668.
PMID: 39222035
Background: The real incidence of atrial arrhythmia (AA) after patent foramen ovale (PFO) closure and whether this complication can be prevented remain unknown. We assessed whether flecainide is effective to...
10.
Wang Y, Zeller M, Auffret V, Georgiopoulos G, Raber L, Roffi M, et al.
Eur Heart J
. 2024 Sep;
45(43):4564-4578.
PMID: 39217456
Background And Aims: Cardiogenic shock (CS) remains the primary cause of in-hospital death after acute coronary syndromes (ACS), with its plateauing mortality rates approaching 50%. To test novel interventions, personalized...